New Pandemic Film Inspired by Recent Events
Nicole Shanahan, who once ran for vice president alongside RFK Jr., is collaborating with renowned author Walter Kahn to produce a film that reflects the ongoing pandemic experience. The project, titled “The Rash,” centers around a public health professor—drawing parallels to the current NIH director. Jay Bhattacharya, a notable critic of COVID-19 lockdowns, is referenced in this storyline as he raised concerns about the mass panic over skin rashes.
Kahn has penned the script, while Shanahan will take on the role of executive producer. Interestingly, Kahn’s earlier work, “Up in the Air,” was adapted into a film starring George Clooney, earning multiple Academy Award nominations.
This film has garnered backing from the Brownstone Institute, which highlights the challenges faced in addressing the pandemic’s aftermath. In a recent appeal for funding, Brownstone mentioned that investors are hesitant about this subject, noting a reluctance within Hollywood to touch it. They stated, “Hollywood elites don’t want this topic produced.”
Brownstone also shared a pitch deck, revealing that “The Rash” draws inspiration from both classic and contemporary political thrillers such as “Dr. Strangelove,” “Thank You for Smoking,” and “Wag the Dog.” The intent is to offer a satirical look at the interplay between public health emergencies and institutional authority.
One of the film’s potential highlights is its exploration of the complicated ties between health agencies and pharmaceutical corporations—a subject ripe for keen satire. However, it raises questions about why Hollywood generally shies away from projects that challenge the status quo. There’s a sense that any critique of figures like Anthony Fauci or the prevailing narrative around public health could be construed as controversial.
There’s a strong hope that this film comes to fruition, as the push for thought-provoking films and art that question institutional authority is more crucial than ever. The realms of public health and big pharma seem like necessary focal points for such a discourse.
